BioCardia, Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $625.0K | $479.0K | $576.0K | $904.0K | — | — | — | $12.0K |
| Cost of Revenue | $517.0K | $690.0K | $746.0K | $1.1M | — | — | $0 | $0 |
| Gross Profit | $108.0K | $-211.0K | $-170.0K | $-157.0K | — | — | $62.0K | $12.0K |
| Gross Margin | 17.3% | -44.1% | -29.5% | -17.4% | — | — | — | 100.0% |
| Operating Expenses | ||||||||
| Research & Development | $8.5M | $5.8M | $3.3M | $1.5M | — | — | — | — |
| SG&A Expense | $5.8M | $6.4M | $4.1M | $3.7M | $196.0K | $259.0K | $401.0K | $630.0K |
| Operating Income | $-14.1M | $-12.4M | $-7.6M | $-5.4M | $231.0K | $9.0K | $-339.0K | $-618.0K |
| Operating Margin | -2,256.3% | -2,589.8% | -1,320.8% | -598.3% | — | — | — | -5,150.0% |
| Interest Expense | — | $0 | $1.7M | $1.4M | — | — | — | — |
| Pretax Income | — | — | — | $322.0K | $234.0K | $19.0K | $-331.0K | — |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — |
| Net Income | $-14.0M | $-12.3M | $-10.3M | $-6.7M | $234.0K | $19.0K | $305.0K | $9.7M |
| Net Margin | -2,237.9% | -2,569.5% | -1,789.9% | -740.8% | — | — | — | 80,516.7% |
| EPS (Basic) | $-1.64 | $-1.45 | $-0.62 | $-2.15 | $0.00 | $0.00 | $0.00 | $0.02 |
| EPS (Diluted) | $-1.64 | $-1.45 | $-0.62 | $-2.15 | $0.00 | $0.00 | $0.00 | $0.02 |
| Shares Outstanding (Basic) | 9.7M | 76.4M | 76.3M | — | — | — | — | — |
| Shares Outstanding (Diluted) | 9.7M | 76.4M | 76.3M | 460.6M | 460.6M | 460.6M | 460.6M | 460.6M |
| Dividends Per Share | — | — | — | — | — | — | — | — |